Halozyme Therapeutics (HALO) Tops Q3 EPS by 5c; Offers FY23 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 125.63 +1.09 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.54 | 52 Week High | $18.39 | |||
| Open | $124.54 | 52 Week Low | $6.96 | |||
| Day High | $126.23 | P/E | N/A | |||
| Day Low | $123.74 | EPS | $-0.58 | |||
| Volume | 1,530,355 | |||||
